Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-06 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
S | Common Stock | D | 25590 | $91.50 - $91.50 | $2,341,485 |
| 2024-11-06 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
M | Common Stock | A | 25000 | $57.92 - $57.92 | $1,448,000 |
| 2024-10-25 | GILEAD SCIENCES, INC. | Telman Deborah H
(EVP, Corporate Affairs & GC) |
F | Common Stock | D | 242 | $89.00 - $89.00 | $21,538 |
| 2024-10-01 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
S | Common Stock | D | 2000 | $83.83 - $83.83 | $167,660 |
| 2024-09-12 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
S | Common Stock | D | 21246 | $84.50 - $84.50 | $1,795,287 |
| 2024-09-12 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
M | Common Stock | A | 25000 | $57.92 - $57.92 | $1,448,000 |
| 2024-09-12 | GILEAD SCIENCES, INC. | Mercier Johanna
(Chief Commercial Officer) |
S | Common Stock | D | 29357 | $83.25 - $84.23 | $2,459,576 |
| 2024-09-10 | GILEAD SCIENCES, INC. | Telman Deborah H
(EVP, Corporate Affairs & GC) |
F | Common Stock | D | 307 | $81.44 - $81.44 | $25,002 |
| 2024-09-10 | GILEAD SCIENCES, INC. | Patterson Sandra
(SVP, Controllership) |
F | Common Stock | D | 292 | $81.44 - $81.44 | $23,780 |
| 2024-09-10 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
F | Common Stock | D | 1766 | $81.44 - $81.44 | $143,823 |
| 2024-09-10 | GILEAD SCIENCES, INC. | O'Day Daniel Patrick
(Chairman & CEO) |
F | Common Stock | D | 4749 | $81.44 - $81.44 | $386,758 |
| 2024-09-10 | GILEAD SCIENCES, INC. | Mercier Johanna
(Chief Commercial Officer) |
F | Common Stock | D | 1734 | $81.44 - $81.44 | $141,216 |
| 2024-09-10 | GILEAD SCIENCES, INC. | Dickinson Andrew D
(Chief Financial Officer) |
F | Common Stock | D | 1682 | $81.44 - $81.44 | $136,982 |
| 2024-08-28 | GILEAD SCIENCES, INC. | Mercier Johanna
(Chief Commercial Officer) |
S | Common Stock | D | 9513 | $78.03 - $78.03 | $742,299 |
| 2024-08-13 | GILEAD SCIENCES, INC. | Mercier Johanna
(Chief Commercial Officer) |
S | Common Stock | D | 5490 | $73.98 - $73.98 | $406,150 |
| 2024-08-10 | GILEAD SCIENCES, INC. | Patterson Sandra
(SVP, Controllership) |
F | Common Stock | D | 980 | $73.66 - $73.66 | $72,186 |
| 2024-07-25 | GILEAD SCIENCES, INC. | Telman Deborah H
(EVP, Corporate Affairs & GC) |
F | Common Stock | D | 2917 | $76.51 - $76.51 | $223,179 |
| 2024-07-01 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
S | Common Stock | D | 2000 | $68.63 - $68.63 | $137,260 |
| 2024-06-10 | GILEAD SCIENCES, INC. | Dickinson Andrew D
(Chief Financial Officer) |
F | Common Stock | D | 1662 | $65.25 - $65.25 | $108,445 |
| 2024-06-10 | GILEAD SCIENCES, INC. | Patterson Sandra
(SVP, Controllership) |
F | Common Stock | D | 255 | $65.25 - $65.25 | $16,638 |
| 2024-06-10 | GILEAD SCIENCES, INC. | O'Day Daniel Patrick
(Chairman & CEO) |
F | Common Stock | D | 4693 | $65.25 - $65.25 | $306,218 |
| 2024-06-10 | GILEAD SCIENCES, INC. | Mercier Johanna
(Chief Commercial Officer) |
F | Common Stock | D | 1714 | $65.25 - $65.25 | $111,838 |
| 2024-06-10 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
F | Common Stock | D | 1744 | $65.25 - $65.25 | $113,796 |
| 2024-06-10 | GILEAD SCIENCES, INC. | Telman Deborah H
(EVP, Corporate Affairs & GC) |
F | Common Stock | D | 204 | $65.25 - $65.25 | $13,311 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |